Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

Diabetes can be expensive to manage ... Your insurance formulary, or the official list of medications that your insurance covers, can help you determine how generics compare in cost to brand ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

The cohort comprised adults age 40 and older with type 2 diabetes who initiated treatment with an SGLT2 inhibitor, DPP-4 inhibitor, or GLP-1 receptor agonist after 2013 and who had active COPD as ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...